Podcasts about screenings

In May 2024, the FDA approved vaginal self-collection for HPV as a cervical cancer screening tool. This was limited to health care settings. While this self collection option can help address some of the emotional deterrents to a speculum examination, it fails to overcome the remaining substantial clinic access barriers cited among those who are underscreened, including time off work, arrangement of child or elder care, and transportation. Then, the FDA approved the first at-home cervical cancer screening test on May 9, 2025. This test, called the Teal Wand (FDA-approved prescription device), allows individuals to self-collect vaginal samples at home to test for Human Papillomavirus (HPV). But is at-home testing valid? Does this work? A new publication in JAMA Network Open (May 19, 2025) answers this important question. Listen in for details.

On this episode of reCappin' with Delora & Ashley, we are live from the Dayton Black Women's Film Festival! We share our thoughts on the screening of "Seeds" by filmmaker Brittany Shyne and recap our experience hosting the post-film Q&A. To check out more on Brittany and her work: https://www.brittanyshyne.com/ We are available on all podcasting platforms but please follow, rate, and review us on Apple Podcasts and Spotify apps. We greatly appreciate the support! Follow us on social media: IG: @recappinpodcast FB: reCappin' with Delora and Ashley Contact us: Email: recappinpodcast@gmail.com

This week, I review the new Tim Robinson/Paul Rudd film from Andrew DeYoung, Friendship in a feature review and then, in this week's secondary review, I share my thoughts on The Weeknd's movie, Hurry Up Tomorrow. I also discuss recent movie news, screenings around Indianapolis, and more.   Timestamps Show Start - 00:28 Screening in Indy - 04:07 News Before the Reviews - 09:40 Feature Review Friendship (2025) - 14:02 Spoiler - 37:08 Secondary Review Hurry Up Tomorrow (2025) - 1:12:25   Closing the Ep - 1:36:36 Patreon Clip - 1:37:43   Related Links Tomato Paste: My Excommunication from Rotten Tomatoes Max Changing back to HBOMax this summer   My 2025 Podcast and Writing Archive Patreon Special - 28 Days Later (2002) at Alamo Drafthouse - May 23, 2025 Immediate Reaction - Clown in a Cornfield (2025) - May 16-21, 2025 Patreon Companion Episodes Collection Companion Ep - OV477 - Final Destination 1-5 Retrospective - May 24-25, 2025 Patreon - Severance Episode Reviews   Indianapolis Theaters Alamo Drafthouse Indy Kan-Kan  Living Room Theaters Keystone Art  Flix Brewhouse   Ways to Support Us Support Us on Patreon for Exclusive Content Official OV Merch Buy Me A Coffee Obsessive Viewer Obsessive Viewer Presents: Anthology Obsessive Viewer Presents: Tower Junkies As Good As It Gets - Linktree Start Your Podcast with Libsyn Using Promo Code OBSESS   Follow Us on Social Media My Letterboxd | YouTube | Facebook | Twitter Instagram | Threads | Bluesky | TikTok | Tiny's Letterboxd   Mic Info Matt: ElectroVoice RE20 into RØDEcaster Pro II (Firmware: 1.5.4)   Episode Homepage: ObsessiveViewer.com/OV476   Next Week on the Podcast OV477 - Final Destination: Bloodlines (2025) & Fear Street: Prom Queen (2025) - Guest: Keegan King

Japan cracks down on weird baby names like Pudding and Pikachu. Cinema ceiling falls on woman during Final Destination: Bloodlines screening in Argentina. 24 year old adult impersonated 17-year-old high school student. // SUPPORT by joining the Weird AF News Patreon http://patreon.com/weirdafnews - OR buy Jonesy a coffee at http://buymeacoffee.com/funnyjones Buy MERCH: https://weirdafnews.merchmake.com/ - Check out the official website https://WeirdAFnews.com and FOLLOW host Jonesy at http://instagram.com/funnyjones

Thanks so much to Dr. Bramante for this interview! You can follow him on social media for more pointers or buy his book (see below), but I think this interview really lays groundwork for aspiring actors...or even folks venturing out into a new career, don't you think? (Don't worry, I'll just bill your insurance for the favor,,,)Follow Dr. Bramante on Instagram : @dralbramanteHere's the Amazon link for "Rise Above The Script": https://www.amazon.com/Rise-Above-Script-Confronting-Performing-ebook/dp/B0CW19F7WZCatch "Sherpa Selects" on Saturdays. It's the episodes you tried to avoid the first time around!More thanks: Music Credits/Voiceovers: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bruce Goldberg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ( aka Lord Mr. Bruce); other Voices: The Sherpa-lu Studio PlayersYouTube: @sherpalution5000 @sherpalution : social media for FB, IG, Bluesky, & TikTokLink page: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠bio.link/jimthepoHere's our website: https://shows.acast.com/the-sherpas-podcast-picksEmail:jimthepodcastsherpa@gmail.comSupport:Review the show on Apple Podcasts or Spotify. Hosted on Acast. See acast.com/privacy for more information.

News with Sean 5-27-2025 ...She Literally Got Crushed at a Screening of Final Destination

AGREE TO DISAGREE: A limit on dogs for commercial dog walkers? // AI is now picking up 911 calls on the Olympic Peninsula // What is going on with Emmanuel and Brigitte Macron? // WE HEAR YOU! and WORDS TO LIVE BY

This week's topics include treating resistant hypertension, gabapentanoids and the risk of self harm, risk for depression after diagnosis of a medical condition, and fatty liver and pregnancy.Program notes:0:35 Depression after medical condition diagnosis1:36 Any of a number of medical conditions2:37 A much lower risk in comparison group3:37 Major depressive disorder could be number one cause of YLL4:01 Fatty liver and pregnancy outcomes5:01 Matched to those with obesity or T2D6:01 Screening general population not indicated7:00 Gabapentanoids and risk of self harm8:01 Rates of self harm variable 9:04 Use has increased fourfold10:00 Treatment of resistant hypertension11:01 Spironolactone or amiloride12:33 End

Welcome to “Onward! A Rose City Podcast”; a place for all your Portland Thorns, Portland Timbers, 107IST, Timbers Army, & Rose City Riveters news, along with stories of our club and culture's history plus a look into the future of soccer support in Portland, Oregon.   ON THIS EPISODE! PTFC Chat: Thorns call-ups, Timbers defeat in the US Open Cup and T2 win streak! Prideraiser Work parties and more! LINKS! Unmatched: The Team That Changed the Beautiful Game RCR TIFO panting Screening at Legends - PCFC Factors Influencing Women's Football Attendance - survey Axe & Rose Work parties: May 25th - May 31st - June 1st Prideraiser: Timbers Army - Rose City Riveters Featured Partner: Frog Pond Farm Supporting Trans Rights Donation Drives Ticket Exchange Facebook - Discord Have a ticket to donate? Send it to ticketdonation@107ist.org 107ist.org

John Maytham speaks to Dr. Mark Faesen, Specialist Gynaecologist and Fertility Specialist with the Clinical HIV Research Unit (CHRU), to unpack what these cuts really mean on the ground. With years of experience in women's reproductive health and HIV care, Dr. Faesen paints a sobering picture of the ripple effects already underway—and what might lie ahead if funding isn't restored. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Many cervical cancers are linked to the HPV virus. However, thanks to screening advancements, early detection of the cancer resulting in effective treatment is possible. Toni Kilts, DO, discusses screening guidelines and cervical cancer prevention.You can also watch the video recording on our Vimeo channel here.For more health tips & news you can use from experts you trust, sign up for Sarasota Memorial's monthly digital newsletter, Healthe-Matters.

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

Is the water you drink every day silently poisoning you—and everyone else on the planet? As toxic “forever chemicals” (PFAS) force regulators and law firms into unprecedented environmental litigation, are we doing enough to protect public health and our communities? This isn't just an environmental debate—it's a real-world legal crisis with real implications. In this episode of Cut to the Chase: Podcast, Gregg welcomes Katrina McGowan, director and producer of the eye-opening documentary “How to Poison a Planet”. Katrina is on the front lines of uncovering global PFAS contamination and the corporate cover-ups behind it. We brought her on to expose how this environmental catastrophe is driving landmark litigation—and why legal professionals must pay attention. Did you know “forever chemicals” are now detected in 98% of human blood around the world—including newborns and even polar bears in the Arctic? And yet, many governments (and industries) are still pretending there's nothing to see here. Listen in as Katrina reveals the dramatic journey behind her film, real stories from legal battles with chemical giants, and exclusive insights on the urgent role lawyers play in environmental justice. What you'll learn in this episode: Why PFAS (“forever chemicals”) are everywhere—from firefighting foam to your drinking water The real story: Katrina's inspiration, research, and shocking revelations while making How to Poison a Planet The human impact: Uncovering health crises in contaminated communities like Wreck Bay, Australia Behind-the-scenes: How lawyers in the U.S. and Australia brought accountability to global corporations (3M and more) Corporate cover ups revealed—what internal documents finally showed about industry knowledge and intent Challenges faced: Government denial and resistance, public ignorance, and regulatory loopholes Screening the documentary for policymakers and its impact on pushing regulatory change Steps individuals and law firms can take to protect themselves and their clients now   Key Takeaways: Spread Awareness: Most people don't know about PFAS risks. Help educate your community. Act Together: Collective efforts—legal, civic, or grassroots—can pressure companies and regulators to act. Demand Transparency: Exposing hidden information can lead to real change. Push for openness. Push for Reform: Public pressure can drive stronger environmental laws and enforcement. Get Ahead of the Risk: Learn your exposure, adopt safer practices, and prepare before harm occurs.   Stay tuned for more updates, and don't miss our next deep dive on Cut to The Chase: Podcast with Gregg Goldfarb!   Subscribe, rate, review, and share this episode of the Cut to the Chase: Podcast!   Resources: Watch “How to Poison a Planet”: https://www.howtopoisonaplanet.com Connect with Katrina McGowan on LinkedIn: https://www.linkedin.com/in/katrina-m-4b12a562   This episode was produced and brought to you by Reignite Media.

Struggling to find the right people—or to keep the good ones? You're not alone. In this episode of Millions Were Made, Jessica Marx sits down with Jen Dillard and Makena Finger Zannini, Co-Founders of Brick by Brick Collective, to share their proven systems for building high-performing teams, designing performance-based compensation, and leading with clarity.Whether you're hiring your first employee or scaling a team of 50+, you'll learn how to write effective job descriptions, create an onboarding process that drives results in the first 90 days, and implement leadership development strategies that boost retention and revenue. They also reveal their approach to incentive compensation plans, how to conduct value-aligned interviews, and what every founder needs to know before making their next hire.If you're a small business owner or CEO scaling to 7 or 8 figures, this conversation is your playbook for building a motivated team, creating an intentional culture, and leading like a visionary.Highlights:(01:00) Why most small business owners overlook leadership development(02:06) Scaling from solopreneur to 100+ team members(03:42) Hiring support without compromising profit margins(04:36) Why you must set high hiring standards early(06:44) The power of performance-based compensation plans(07:55) Stop writing job descriptions that combine 4 different roles(08:38) Corporate experience vs. small business agility(09:45) How to improve your interview process with test projects(11:45) Screening for emotional intelligence in sales roles(13:10) A proven 90-day onboarding process for employee success(16:01) Why new hires don't magically fix your business(17:25) Leveraging feedback from fresh team members(18:39) Creative incentive plans that increase employee motivation(22:39) Building a strong company culture—remote or in-person(24:24) Handling low team morale or underperformance(25:17) How to have tough conversations without fear or guilt(29:18) Making data-driven decisions when managing people(30:44) How personal wealth creates freedom and legacy impactConnect with Jessica:Instagram: @millionsweremade | @thejessicamarxWork with Jessica: Tailored PremierWebsite: Millions Were MadeConnect with Jen & Makena:Website https://www.brickbybrickcollective.com/Connect with Jen and Makena on Instagram: @jendillard and @makenafzLinkedIn: https://www.linkedin.com/in/hilarythecfp/

In this episode, we dive into the importance of autoantibody screening for Type 1 Diabetes (T1D) and its potential for early detection. Learn how identifying at-risk individuals can improve patient outcomes, reduce complications and help guide timely interventions.

I'm not one to leave "inside jokes" in my interviews, so just for reference; 1. "Beautiful Downtown Burbank" was referenced in the 1960's/'70's tv show, "Rowan & Martin's Laugh-In" which aired YEARS before Rich was born; and 2, I opened the wrong video application to record the interview, but luckily, Rich appeared...like magic! So, speaking pf magic, be sure to check out Rich's show on Tubi, "Culture Shock". where you will see much magic, and of course, be amazed. If you haven't caught it yet, get ready for an absolutely fascinating interview here (his part, not mine) where we are chatting about magic, and the world around us. Thanks for coming on the show, Rich!Follow Rich on Instagram: @richcmanley or Facebook: https://www.facebook.com/EverythingRichManley/ Website: www.expeditionrich.comCatch "Sherpa Selects" on Saturdays. It's the episodes you tried to avoid the first time around!More thanks: Music Credits/Voiceovers: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bruce Goldberg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ( aka Lord Mr. Bruce); other Voices: The Sherpa-lu Studio PlayersYouTube: @sherpalution5000 @sherpalution : social media for FB, IG, Bluesky, & TikTokLink page: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠bio.link/jimthepoHere's our website: https://shows.acast.com/the-sherpas-podcast-picksEmail:jimthepodcastsherpa@gmail.comSupport:Review the show on Apple Podcasts or Spotify. Hosted on Acast. See acast.com/privacy for more information.

Drs. Pemmaraju and Bose discuss the revised International Working Group criteria for anemia response in patients with myelofibrosis, outlining new definitions for transfusion status, gender-specific hemoglobin thresholds, and benchmarks for major and minor responses.

We watch this uneven but fascinating movie about teens, fads, feminism, and the universal shittiness of rock dudes. Check out our letterboxd list if you'd like to see all the movies covered that way!Send us any email questions and comments about the movies we cover or movies in general to abnormalmappingpodcast@gmail.com!Also, we're a patreon supported show, please go to patreon.com/abnormalmapping to see our many shows and support us.Next Time on Repertory Screenings: The Day of the Jackal

In this episode of the Heal Your Homes podcast, Dr. Danielle Desroche shares her experience with Prenuvo, a non-invasive MRI screening tool designed to detect potential health issues early. She discusses her motivations for undergoing the scan, the process of scheduling and preparing for it, her experience during the scan, and the results she received. Dr. Desroche emphasizes the importance of early detection and the potential life-saving benefits of such screenings, while also addressing the limitations and challenges of the process.Click here to learn more about Prenuvo. Code PHYSDANIELLEDESROCHE300 will save you $300 on your next scan.-----Have a topic you want covered? DM me on Instagram @drdanielle.nd⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Schedule your strategy call here.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join the newsletter here!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fullscript Supplement Dispensary⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Last year the government announced it's progressively lowering eligibility for free bowel cancer screening to 58 years old, down from 60. It also ended a pilot programme that allowed Maori and Pasifika to access bowel screening at 50. That's despite Christopher Luxon's pre-election promise to match Australia's screening age of 45 years old. Rachael Ferguson spoke to Lisa Owen. 

Cancer—just the word alone can spark fear and anxiety. And today, we're going to talk about it. Fearlessly.In this episode, Dr. Stephen Petteruti discusses the practicalities and pitfalls of common cancer screening methods, specifically for esophageal and colon cancer, for less invasive and safer alternatives like nasal endoscopy and Cologuard. He also shares the profound impact that lifestyle choices, particularly diet, obesity management, and toxin avoidance, can have on reducing cancer risk.Learn actionable tips for nurturing your immune system, the importance of sleep, managing inflammation, and avoiding known carcinogens.Tune in to this episode to gain valuable strategies and insights! Fear, Food & Prevention: The Truth About Cancer, Screening, and Immune Power.Key Points:00:00 Introduction01:04 Fear as a driver in cancer screening01:39 Cancer is largely environmental05:12 Preventative drugs06:17 Carcinogens accumulative effects07:34 Esophageal cancer08:09 Barrett's esophagitis10:12 Serious complications from an EGD14:22 Watch your diet15:18 Colon cancer screening18:25 Cologuard20:05 Two basic kinds of polyps21:28 Prevention mindsetEnjoy the podcast? Subscribe and leave a 5-star review on your favoritePlatforms.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com  YouTube: https://www.youtube.com/@dr.stephenpetteruti LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/dr.stephenpetteruti Produced by https://www.BroadcastYourAuthority.com#CancerScreening #PreventiveCare #GutHealthDisclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.

In today's VETgirl online veterinary continuing education podcast, Dr. Michelle Evason, BSc, DVM, DACVIM, MRCVS, Global Director of Veterinary Clinical Education at Antech, and Dr. Jimmy Barr, DACVECC, Chief Medical Officer at Antech, part of Mars Science & Diagnostics, discuss vector borne disease including spectrum of care. Screening dogs for vector-borne disease pathogens, like Lyme and Heartworm, occurs annually in veterinary clinics across the US and Canada. Listen in for updates on innovations and practical pearls on pet-owner communication & shared-decision-making across the diagnostic spectrum of care.Sponsored By: Antech, MARS

Join Kara and Jeremy we muck around with making custom Star Wars characters! We also reminisce about our favorite Star Wars experiences, ramble on with stories of the good ol' days, nerd out about current and upcoming Star Wars shows, books, and games, and talk a little bit about life. Thank you so much for supporting our channel! We love interacting with all of you! We look forward to talking with you guys every week about Star Wars, gaming, 3D printing, pop culture, movies, and everything else! If you want to show your love, consider sending us an email, joining our Discord, or following us on Twitch! We'll see you again soon! ------------------------------------------------------------------- Twitch: http://www.twitch.tv/riseofthepodcast Discord Server Link: https://discord.gg/DcuBKXVxJs Email us: contact@RiseOfThePodcast.com Facebook: https://www.facebook.com/riseofthepodcast Web: http://www.riseofthepodcast.com Twitter: http://www.twitter.com/rotptweets Instagram: https://www.instagram.com/riseofthepodcast Patreon: https://www.patreon.com/RiseofthePodcast Spotify: https://spoti.fi/3qzOazE iTunes: https://apple.co/3wAfwcI Google Podcasts: https://bit.ly/RotPGoogle Thanks for watching! Rise of the Podcast Episode 306: Star Wars Fan Art and Symphonic Screenings Produced and Edited by 8r0wn13 ©2025 All Rights Reserved #Podcast #DuluthMN #StarWars

In this episode of the Dyslexia Explored Podcast, host Darius Namdaran welcomes Nora Fink, co-founder and co-CEO of ever-growing GBH, to discuss innovations in dyslexia screening using AI and handwriting analysis. Nora shares her personal journey with dyslexia, spurred by her son's diagnosis, and how it led to the development of the Dyslexia 99 program. The conversation delves into the program's pilot studies, achieving over 99% accuracy in detecting dyslexia, and the potential for early detection and intervention in schools. They explore advancements in AI, challenges in the current education system, and the future of personalized learning for children with dyslexia.Link:Ever Growing GBH ever-growing.de/ Nora Fink Linkedin: linkedin.com/in/norafinkDyslexie Font how to acquire: https://dyslexiefont.com/en/ Elevenlabs ai: https://elevenlabs.io/This podcast is sponsored by: Dyslexia productivity coaching?: http://dyslexiaproductivitycoaching.com/ Dyslexia Quiz: https://bulletmapacademy.com/dyslexia-quiz/Bulletmap Academy: https://bulletmapacademy.comHow to Mindmap: https://www.bulletmapacademy.com/courses  Ai and Mindmapping Training: https://www.ivvi.app/ai-mindmapping Interested in being a guest? Email us at info@bulletmapacademy.com

Japanese director Genki Kawamura brings the cult video game "Exit 8" to the big screen in a chilling psychological thriller. Premiering in Cannes' Midnight Screenings section, the film follows a man trapped in a looping subway corridor, desperately searching for a way out. Adapted from a 2023 indie hit, it's a tense, mind-bending ride already thrilling both gamers and film fans. 

Host Ally Pitts shares some news about a screening of Andrei Tarkovsky's Mirror that he'll be introducing on Sunday 25th May as part of the Dreamscapes classic season at Ultimate Picture Palace in Oxford. He also shares news about screenings of Soviet films at the Prince Charles Cinema, and shares details of silent film screenings with live music by Hugo Max. Links mentioned/alluded to in the episode: Dreamscapes classic season at Ultimate Picture Palace in Oxford https://uppcinema.com/show_type/classic-season-dreamscapes/  Antifa on screen classic season at the UPP https://uppcinema.com/show_type/classic-season-antifa-on-screen/ Come and See & Elem Klimov https://www.podchaser.com/podcasts/a-russian-soviet-movie-podcast-594862/episodes/come-and-see-elem-klimov-1985-41611107  https://uppcinema.com/show/come-and-see/ https://letterboxd.com/thetop100/list/the-greatest-films-ever-made-as-selected/  https://www.criterion.com/films/28895-come-and-see The Prince Charles Cinema, Leicester Square, London https://princecharlescinema.com/seasons-events/bleak-week/ https://princecharlescinema.com/seasons-events/tarkovsky/   https://princecharlescinema.com/film/6773592/the-colour-of-pomegranates-sayat-nova/  https://princecharlescinema.com/film/20569368/the-cranes-are-flying/  https://princecharlescinema.com/film/1865782/battleship-potemkin-bronenosets-potyomkin/ https://princecharlescinema.com/whats-on/   Hugo Max scores silent cinema https://hugomax.co.uk/news  https://hugomax.co.uk/upcoming-past-performances  Contact us/socials: All the links for a Russian & Soviet Movie Podcast and Ally Pitts you're ever likely to want or need: linktr.ee/russiansovietmoviepodcast linktr.ee/ally_pitts  We changed the name of the show a little while back, but the social handles/contacts are a bit of a mishmash. Email: russophilesunite@gmail.com Letterboxd: letterboxd.com/Ally_Pitts/ Instagram: instagram.com/russiansovietmoviepodcast/  instagram.com/ally_pitts_movies_etc/  Listen to Ally's other podcast appearances on Podchaser

“A lot of other disease sites, they have some targeted therapies, they have some immunotherapies [IO]. In lung cancer, we have it all. We have chemo. We have IO. We have targeted therapies. We have bispecific T-cell engagers. We have orals, IVs. I think it's just so important now that, particularly for lung cancer, you have to be well versed on all of these,” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer treatment. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 16, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer treatments. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episode: Episode 359: Lung Cancer Screening, Early Detection, and Disparities ONS Voice articles: Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Oncology Drug Reference Sheet: Amivantamab-Vmjw Oncology Drug Reference Sheet: Cisplatin Oncology Drug Reference Sheet: Lazertinib Oncology Drug Reference Sheet: Nivolumab and Hyaluronidase-Nvhy Oncology Drug Reference Sheet: Fam-Trastuzumab Deruxtecan-Nxki Optimize Your Testing Strategy and Improve Patient Outcomes With NeoGenomics' Neo Comprehensive™–Solid Tumor Assay Clinical Journal of Oncology Nursing article: Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice Nurse ONS Biomarker Database ONS video: What is the role of the KRAS biomarker in NSCLC? Biomarker Testing in Non-Small Cell Lung Cancer Discussion Tool ONS Huddle Cards: Checkpoint inhibitors External beam radiation Monoclonal antibodies Proton therapy To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, because lung cancer is pretty aggressive, we'll see lung cancer mostly in stage IV. So about 50%–55% of all cases are not caught until they are already metastatic, or stage IV. And then about another 25%–30% of cases are caught in stage III, which means they're locally advanced and often not resectable, but we do still treat that with curative intent with concurrent chemoradiation. And then 10%–20% of cases are found in the early stage, and that's stage I and II, where we can do surgical approaches.” TS 2:53 “The majority of radiation that you're going to see is for patients with stage III disease that's inoperable. At my institution, a lot of stage III is inoperable. Now, neoadjuvant immunotherapy has changed that a little bit. But if you have several big, bulky, mediastinal lymph nodes that makes you stage III, surgery is probably not going to be a great option. So we give curative-intent chemoradiation to these patients.” TS 10:51 “Oligoprogression would mean they have metastases but only to one site. And sometimes we will be aggressive with that. Particularly, there's good data, if the only site of progression is in the brain, we can do stereotactic radiation to the brain and then treat the chest with concurrent chemoradiation as a more definitive approach. But outside of that, the majority of stage IV lung cancer is going to be treated with systemic therapy.” TS 15:00 “It's important for nurses to know that there's a lot of different options now for treatment. Probably one of the most important things is making sure patients are aware of what their biomarker status is, what their PD-L1 expression level is, and make sure those tests have been done. … It's good that the patients understand that there's a myriad of options. And a lot of that depends on what we know about their cancer, and then that guides our treatment.” TS 31:05

About this episode: Diagnoses of autism are on the rise, but is this the result of more children being affected by the condition, or is more of a consequence of broader criteria and more screening? In this episode: a look at a new study about the number of children diagnosed with autism and what this research shows—and doesn't show. Guest: Dr. Christine Ladd-Acosta is an autism researcher and vice-director of the Wendy Klag Center for Autism and Developmental Disabilities. She is the lead Maryland investigator on a national study about the rate of autism. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Prevalence and Early Identification of Autism Spectrum Disorder Among Children Aged 4 and 8 Years - Autism and Developmental Disabilities Monitoring Network, 16 Sites, United States 2022—CDC's MMWR RFK Jr.'s autism study to amass medical records of many Americans—CBS News The NIH-Funded Autism Study Hoping to Pinpoint Gene-Environmental Interplay—Public Health On Call (March 2025) Vaccines Don't Cause Autism. Why Do Some People Think They Do?—Hopkins Bloomberg Public Health Discovering How Environment Affects Autism—Hopkins Bloomberg Public Health Magazine (2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Tracey Ryniec, Zacks Value Stock Strategist, finds 3 value stocks with Strong Buy and Buy recommendations. (0:30) - Getting Back To The Basics With Value Stock Screening (6:00) - Tracey's Top Stock Picks To Keep On Your Radar Right Now (26:40) - Episode Roundup: CNC, CPA, KB

In this episode, we interview Christina Campero, an entrepreneurial force behind Prosperia, a tech startup focused on AI in healthcare. Christina discusses her professional journey, moving from a background in bioscience and healthcare consulting to co-founding Prosperia. The startup uses AI to scan retina images for early detection of diabetic retinopathy and other eye diseases, a crucial service in Mexico due to a high prevalence of diabetes and limited access to ophthalmologists. The conversation covers the development process of their AI model, partnerships with primary healthcare touchpoints, and the advantages of operating in Mexico. They also explore the challenges and breakthroughs in fundraising for a Latin American AI healthcare startup, including securing a seed round from a Swedish fund. The episode ends with a look at Prosperia's future goals, including expanding their AI applications to detect other health conditions.   If your company is looking to scale its AI initiatives, head over to Tesoro AI (www.tesoroai.com). We are experts in AI strategy, staff augmentation, and AI product development.   Founder Bio:   Cristina Campero graduated from the Faculty of Chemistry of the UNAM with a Master's Degree in Bioscience Enterprise from the University of Cambridge in the United Kingdom. She has dedicated her professional career to the transformation of ideas into commercial products with an impact on health, starting in her career as a consultant at McKinsey & Company and in start-ups, first as an Associate in business development and strategy at Wren Therapeutics (in Cambridge UK ) where she was in charge of portfolio prioritization and funding (£18M Series A in Dec. 2018), and now as CEO of PROSPERiA.      Time Stamps:   00:36 Christina's Professional Journey 04:00 Founding Prosperia and Developing Retinia 05:43 Addressing Diabetic Retinopathy with AI 07:10 Challenges in Diabetic Retinopathy Detection 09:32 AI's Role in Early Detection and Screening 13:33 How does the Retinia software diagnosis work 15:20 The role of AI versus human doctors 20:43 Building and Training AI Models 24:31 Balance between engineers and health care professionals 26:14 Creating a customer base that trusts AI diagnosis 32:53 Fundraising and Growth Strategies 40:45 Advantages of Fundraising in Latin America Compared to the U.S. 44:01 Future Plans and Innovations   Resources   Follow Darius Gant LinkedIn - https://www.linkedin.com/in/m-darius-gant-cpa-44650aa/ Company Website - www.tesoroai.com     Subscribe on Spotify: https://open.spotify.com/show/4uDVNgsK3iNeu7yU4Inu2n   Subscribe on Apple Podcast: https://podcasts.apple.com/ae/podcast/the-darius-gant-show/id1527996104   Company website: https://www.prosperia.health/es LinkedIn: https://www.linkedin.com/company/prosperia/ https://www.linkedin.com/in/cristina-campero-peredo-a87a15115/  

This week, Brent Leuthold joins me to review the the new MCU film from director Jake Schreier, Thunderbolts* in a feature review and then, in this week's secondary review, we discuss the new James Madigan movie, Fight or Flight. We also discuss recent movie and TV news, screenings around Indianapolis, and more.   Timestamps Show Start - 00:28 Introducing Brent - 02:31 Screening in Indy - 07:41 News Before the Reviews - 11:40 Feature Review Thunderbolts* (2025) - 40:28 Spoiler - 1:05:40 Secondary Review Fight or Flight (2025) - 1:35:00 Closing the Ep - 1:58:28 Patreon Clip - 2:00:10   Related Links ‘Alien: Earth', ‘The Bear' Season 4 & ‘The Lowdown' Get Premiere Dates At FX, Hulu & Hulu On Disney+ ‘Creed' Universe TV Series ‘Delphi' Ordered By Amazon With Michael B. Jordan Executive Producing Peacock's ‘The Office' Followup Series ‘The Paper' Sets Premiere   My 2025 Podcast and Writing Archive Immediate Reaction - Drop (2025) - Apr 7, 2025 Patreon Companion Episodes Collection Companion Ep - OV467 - Akeelah and the Bee (2011) & The Girl is in Trouble (2015) - Feb 26-Mar 1, 2025 Patreon - Severance Episode Reviews   Brent's Review of Fight or Flight (2025) Brent's Review of Thunderbolts* Brent's Review of Sinners (2025) Brent's Review of Drop (2025)   Indianapolis Theaters Alamo Drafthouse Indy Kan-Kan  Living Room Theaters Keystone Art  Flix Brewhouse   Ways to Support Us Support Us on Patreon for Exclusive Content Official OV Merch Buy Me A Coffee Obsessive Viewer Obsessive Viewer Presents: Anthology Obsessive Viewer Presents: Tower Junkies As Good As It Gets - Linktree Start Your Podcast with Libsyn Using Promo Code OBSESS   Follow Us on Social Media My Letterboxd | YouTube | Facebook | Twitter Instagram | Threads | Bluesky | TikTok | Tiny's Letterboxd   Mic Info Matt: ElectroVoice RE20 into RØDEcaster Pro II (Firmware: 1.5.4) Brent: Earthworks ICON Pro in Google Meet   Episode Homepage: ObsessiveViewer.com/OV475   Next Week on the Podcast OV476 - Hurry Up Tomorrow (2025) & TBD (2025)  

Communicating on the phone should be simple, but now it's becoming extremely tedious.

Making phone calls isn't so simple anymore.

If you're looking for exciting things to do this weekend, Soundside Producer Jason Megatron Burrows is here with MOST of the stuff you can get up to. Okay, SOME of the stuff you can get up to. Also, one quick correction: Jason erroneously said University AVE instead of University WAY when talking about the U-District Street Fair - it's here in the U-District, NOT in Downtown Seattle. LINKS: POW! Screening at the Tulalip Reservation Seattle International Film Festival!! Meet Me Here SIFF Episode! Never Turn Back Exhibit Opening Party: Soul Train Revival Smash Putt - FINAL WEEKEND Rig-a-palooza 2025 Dozer Days Amazing Bubble Man POP Cats Seattle 2025 U District Street Fair Viking Fest - Poulsbo, WA The Seattle Super Saunter Gays Eating Garlic Bread in the Park Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

Tracey Ryniec, Zacks Value Stock Strategist, finds 3 value stocks with Strong Buy and Buy recommendations. (0:30) - Getting Back To The Basics With Value Stock Screening (6:00) - Tracey's Top Stock Picks To Keep On Your Radar Right Now (26:40) - Episode Roundup: CNC, CPA, KB Podcast@Zacks.com

At-home cervical cancer screening device gains clearance; the FDA indicates it wants to remove pediatric fluoride products from the market; the chikungunya vaccine is put on-pause for some individuals; a subcutaneous autoinjector is approved to treat migraines; and the FDA will review a gene therapy for Hunter syndrome.

Send us a textLinden Schaffer is an award‑winning wellness entrepreneur, bestselling author, and expert with over 20 years of experience in the wellness and psychedelic spaces. She is the founder of Reveal, a global online community for women, and the co‑founder of the Los Angeles Women's Psychedelic Community—both dedicated to creating safe, supportive, and informed spaces where women can thrive through trust, education, and connection. As a member of the Global Psychedelic Society team, Linden contributes to fostering responsible and inclusive practices within the growing psychedelic movement.In this episode, we discuss the world of psychedelics and their therapeutic potential for addressing trauma, anxiety, depression, and other mental‑health challenges. Linden introduces her Five Ss of psychedelic risk reduction framework—Screening, Set, Setting, Support, and Sustainability—to ensure safe and informed use. We also cover micro-dosing, the history and legality of psychedelics, and the importance of robust education and support systems. I absolutely loved this conversation—we haven't had an expert on this topic before, and the emerging research is truly exciting. Find Linden: 

Do you know the answer?Well if you do, keep it to yourself and join us on Saturday with plenty of popcorn for a film that has quite rightly become the stuff of legend here at the House Of Hammer!Here's the key to the mystery...

I hope that the fact that we've covered 2 true crime editors who write about murders in Michigan isn't making you reconsider your vacation time! I know the Detroit Metro Airport, and I can safely say that me or my pilot was never murdered there. Anyway, thanks so much to Rod for coming on. Here's the link to his book, along with his website, where you can check out his other books, too!Website: https://www.rodsadler.com/https://www.amazon.com/stores/Rod-Sadler/author/B00W1Q2QUS?ref=sr_ntt_srch_lnk_2&qid=1746935266&sr=8-2&isDramIntegrated=true&shoppingPortalEnabled=trueProgramming note: Catch "Sherpa Selects" on Saturdays. It's the episodes you tried to avoid the first time around!Music Credits/Voiceovers: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Sherpa-lu Studio Players; Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/goods-cargo/blurLicense code: SEGQXRLESQA3PHDZYouTube: @sherpalution5000 @sherpalution : social media for FB, IG, Bluesky, & TikTokLink page: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠bio.link/jimthepoHere's our website: https://shows.acast.com/the-sherpas-podcast-picksEmail:jimthepodcastsherpa@gmail.comSupport:Review the show on Apple Podcasts or Spotify Hosted on Acast. See acast.com/privacy for more information.

In this thrilling installment of Impact Theory, Tom Bilyeu sits down with Ben Lamm, visionary founder and CEO of Colossal Biosciences, a company on a mission to reverse extinction and rewrite the future of conservation and synthetic biology. Ben and Tom dive deep into the mind-bending world of de-extinction, synthetic gene editing, and how the CRISPR revolution is not only unlocking the secrets of life—but also actively engineering it. In Part 1, get ready for a rollercoaster of concepts as Ben explains the technical magic behind gene editing, DNA synthesis, and multiplex genome editing. From the birth of the woolly mouse to the debated revival of dire wolves, Ben reveals the breakthroughs, challenges, and wild stories behind reviving extinct species. You'll learn how Colossal is using advanced computational biology, AI, and hands-on bioengineering to not only bring animals back but also reshape the future of healthcare, genetics, and ethical decision-making. This is part sci-fi, part practical science, and 100% mind-blowing. SHOWNOTES 00:00 – Kicking Off: The Mysteries of Editing Life 00:14 – Emergence of the CRISPR Revolution 01:31 – What Is DNA Synthesis and Multiplex Editing? 03:47 – The Woolly Mouse: Engineering Traits Across Species 07:54 – Breaking Down the Process: IVF, Screening, and Sequencing 09:24 – Mapping Genotype to Phenotype and Its Challenges 12:10 – Targeting Gene Edits: From Theory to Application in Health and Conservation 17:09 – From Hair Organoids to Building Mammoth Traits in Mice 24:41 – The Quest for a Universal Egg and Overcoming Cellular Barriers 26:17 – Artificial Wombs: The Next Frontier in Conservation and Science 31:12 – Scaling Conservation and Bridging to Human Healthcare FOLLOW BEN LAMM Twitter/X: @federallamm LinkedIn: Ben Lamm CHECK OUT OUR SPONSORS ButcherBox: Ready to level up your meals? Go to ⁠https://ButcherBox.com/impact⁠ to get $20 off your first box and FREE bacon for life with the Bilyeu Box! Vital Proteins: Get 20% off by going to ⁠https://www.vitalproteins.com⁠ and entering promo code IMPACT at check out Shopify: Sign up for your one-dollar-per-month trial period at ⁠https://shopify.com/impact⁠ Netsuite: Download the CFO's Guide to AI and Machine Learning at ⁠https://NetSuite.com/THEORY⁠ iTrust Capital: Use code IMPACTGO when you sign up and fund your account to get a $100 bonus at ⁠https://www.itrustcapital.com/tombilyeu⁠  Mint Mobile: If you like your money, Mint Mobile is for you. Shop plans at ⁠https://mintmobile.com/impact.⁠  DISCLAIMER: Upfront payment of $45 for 3-month 5 gigabyte plan required (equivalent to $15/mo.). New customer offer for first 3 months only, then full-price plan options available. Taxes & fees extra. See MINT MOBILE for details. What's up, everybody? It's Tom Bilyeu here: If you want my help... STARTING a business: join me here at ZERO TO FOUNDER SCALING a business: see if you qualify here. Get my battle-tested strategies and insights delivered weekly to your inbox: sign up here. ********************************************************************** If you're serious about leveling up your life, I urge you to check out my new podcast, Tom Bilyeu's Mindset Playbook —a goldmine of my most impactful episodes on mindset, business, and health. Trust me, your future self will thank you. ********************************************************************** LISTEN TO IMPACT THEORY AD FREE + BONUS EPISODES on APPLE PODCASTS: apple.co/impacttheory ********************************************************************** FOLLOW TOM: Instagram: https://www.instagram.com/tombilyeu/ Tik Tok: https://www.tiktok.com/@tombilyeu?lang=en Twitter: https://twitter.com/tombilyeu YouTube: https://www.youtube.com/@TomBilyeu Learn more about your ad choices. Visit megaphone.fm/adchoices

The FiltrateJoel TopfAC GomezSophia AmbrusoNayan AroraSpecial Guest Charles Edelstein, MD, PhD Professor, Medicine-Renal Med Diseases/HypertensionExtra-Special GuestMichelle Rheault, MD Professor of Pediatrics, University of MinnesotaEditing bySimon and Joel TopfThe Kidney Connection written and performed by by Tim YauShow NotesKDIGO ADPKD Guidelines:WebsiteGuideline PDFExecutive Summary PDFNephJC coverageConsortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP)Hy's Law (Wikipedia) has three components:ALT or AST by 3-fold or greater above the upper limit of normalAnd total serum bilirubin of greater than 2× the upper limit of normal, without findings of cholestasis (defined as serum alkaline phosphatase activity less than 2× the upper limit of normal)And no other reason can be found to explain the combination of increased aminotransferase and serum total bilirubin, such as viral hepatitis, alcohol abuse, ischemia, preexisting liver disease, or another drug capable of causing the observed injuryMeeting this definition yields a very high risk of fulminant kidney failure (76% in one series)Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database (PubMed) Two of 957 patients on tolvaptan met Hy's law criteria. None had fulminant kidney failure.Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial (PubMed) Patients had a baseline urine volume on tolvaptan of 6.9 L/24 h. Urine volume decreased to 5.1 L/24 h with hydrochlorothiazide and to 5.4 L/24 h on metformin.TEMPO 3:4 Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (NEJM)Reprise Trial Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease ( NEJM | NephJC )Unified ultrasonographic diagnostic criteria for polycystic kidney disease by Edelstein in JASN (PubMed)Tolvaptan and Kidney Function Decline in Older Individuals With Autosomal Dominant Polycystic Kidney Disease: A Pooled Analysis of Randomized Clinical Trials and Observational Studies (PubMed)Charles' draft choice Recommendation 4.1.1.1: We recommend initiating tolvaptan treatment in adults with ADPKD with an estimated glomerular filtration rate (eGFR) ‡25 ml/min per 1.73 m2 who are at risk for rapidly progressive disease (1B).Sophia's draft choice Recommendation 1.4.2.1: We recommend employing the Mayo Imaging Classi cation (MIC) to predict future decline in kidney function and the timing of kidney failure (1B).Progression to kidney failure in ADPKD: the PROPKD score underestimates the risk assessed by the Mayo imaging classification (Frontiers of Science)AC's draft choice Recommendation 9.2.1: We recommend targeting BP to ≤ 50th percentile for age, sex, and height or ≤ 110/70 mm Hg in adolescents in the setting of ADPKD and high BP (1D).HALT-PKD Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease (NEJM)Nayan's draft choice Recommendation 6.1.2: We recommend screening for ICA in people with ADPKD and a personal history of SAH or a positive family history of ICA, SAH, or unexplained sudden death in those eligible for treatment and who have a reasonable life expectancy (1D).Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease (CJASN)Surgical Clipping Versus Endovascular Coiling in the Management of Intracranial Aneurysms (PubMed) Clipping is associated with a higher rate of occlusion of the aneurysm and lower rates of residual and recurrent aneurysms, whereas coiling is associated with lower morbidity and mortality and a better postoperative course.Joel's editorial pick Recommendation 6.1.1: We recommend informing adults with ADPKD about the increased risk for intracranial aneurysms (ICAs) and subarachnoid hemorrhage (1C).Joel's first draft pick The bring out your dead pick:Recommendation 4.3.1: We recommend not using mammalian target of rapamycin (mTOR) inhibitors to slow kidney disease progression in people with ADPKD (1C).Recommendation 4.4.1: We suggest not using statins specfiically to slow kidney disease progression in people with ADPKD (2D).Recommendation 4.5.1: We recommend not using metformin specifically to slow the rate of disease progression in people with ADPKD who do not have diabetes (1B).Recommendation 4.6.1: We suggest that somatostatin analogues should not be prescribed for the sole purpose of decreasing eGFR decline in people with ADPKD (2B).Perfect match: mTOR inhibitors and tuberous sclerosis complex (Orphanet Journal of Rare Diseases)Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc. (BioSpace) This is press release about acquiring the mTor1 inhibitor.Joel's second draft pick Recommendation 4.2.1.1: We suggest adapting water intake, spread throughout the day, to achieve at least 2–3 liters of water intake per day in people with ADPKD and an eGFR ≥ 30 ml/min per 1.73 m2 without contraindications to excreting a solute load (2D).Nayan's bonus draft Practice Point 4.7.1: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) should not be used to slow eGFR decline in people with ADPKD.Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan (KIReports)SMART Trial of GLP-1ra in non-diabetics: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial (PubMed)Tubular SecretionsNayan: Landman on Paramount Plus (IMDB)Sophia: PassNayan: steps in with The Pitt on HBO (Wikipedia)Charles: The White Lotus, Yellowstone 1923, Poirot (IMDB)AC: The PittMichael Crichton's Estate Sends The Pitt to the Courtroom (Vulture)Joel: I Must Betray you by Ruta Sepetys (Amazon)

Today, I sit down with Dr. Christy Sutton, author of The Iron Curse and an expert whose personal journey through her husband's long and confusing health saga opened her eyes to the often-missed danger of hereditary hemochromatosis.    What we discuss: Meet Dr. Christy Sutton and Her Personal Story ... 00:06:00 Hemochromatosis: Genetics, Diagnosis, and Mistreatment ... 00:11:00 Multi-Organ Impact of Iron Overload ... 00:33:00 Childhood Hemochromatosis and Clinical Blind Spots ... 00:37:00 A five-year-old's story reveals difficulties in pediatric diagnosis and innovative, non-blood-removal strategies. Symptoms, Infections, and Iron ... 00:47:00 Systemic issues like joint pain, anxiety, dementia, and heightened risk of deadly infections. Managing and Lowering Iron Levels ... 01:01:00 Genetic Roots: Red Hair, Irish Heritage, and Family Risk ... 01:09:00 Key Takeaways and Resources ... 01:17:00 Screening recommendations, where to find Dr. Sutton's work, and closing comments for listeners.   Our Amazing Sponsors: Puori: If you want clean, high-quality protein without the mystery contaminants, check out Puori PW1. Receive 20% off a one-time purchase or if you choose the already discounted subscription, you get almost a third off the price! Visit Puori.com/NAT and use my promo code NAT.   Young Goose L.A.D.R. Serum -  Powered by light-activated DNA repair enzymes, NAD+, and collagen peptides, it reverses damage while you go about your life. Sunlight? Red light therapy? It all helps this serum work smarter, not harder. Visit YoungGoose.com—use code NAT10 to get started, or 5NAT if you're an existing customer. Future-proof your face.   Fresh-Pressed Olive Oil Club: As an introduction to his Fresh-Pressed Olive Oil Club, T. J. is willing to send you a full-size $39 bottle of one of the world's finest artisanal olive oils — fresh from the new harvest—for just $1 to help him cover shipping. No commitment to buy anything, now or ever. Go to GetFreshLongevity.com for a free bottle and pay just $1.   Nat's Links: YouTube Channel Join My Membership Community Sign up for My Newsletter  Instagram  Facebook Group

Tracey Ryniec, Zacks Value Stock Strategist, uses Zacks Research Wizard's Buffett screen to find value stocks.   (0:30) - Using Warren Buffett To Find Strong Value Investments (4:30) - Top Stocks To Keep On Your Radar Right Now (25:40) - Episode Roundup: DFH, KO, AMZN  

Tracey Ryniec, Zacks Value Stock Strategist, uses Zacks Research Wizard's Buffett screen to find value stocks.   (0:30) - Using Warren Buffett To Find Strong Value Investments (4:30) - Top Stocks To Keep On Your Radar Right Now (25:40) - Episode Roundup: DFH, KO, AMZN Podcast@Zacks.com  

A live post screening q and a with Director Remsi Atasi and Producer Sal Abibinanti at Chicago's Music Box Theater 

US and Chinese officials are meeting in person for the first time since their tit-for-tat trade war began. Blackouts have been reported in several cities in India amid escalating clashes with Pakistan. We have new developments on the high-profile arrest of a Tufts University student from Turkey. President Donald Trump made a notable change for one position after pushback from Republicans. Plus, the first cervical screening device that can be used at home. Learn more about your ad choices. Visit podcastchoices.com/adchoices